e-Article
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance
Document Type
Article
Author
Source
In Blood 1 April 2008 111(7):3735-3741
Subject
Language
ISSN
0006-4971